Evidence map›Paper›PMID 27446366›Full record

ArticleOncology letters2016

Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells

Ri-Xiong Wang, Hui Liu, Li Xu, Hui Zhang, Rui-Xiang Zhou

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Melatonin for gastric cancer treatment: where do we stand?Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. ROR: Nuclear Receptor for Melatonin or Not?Molecules (Basel, Switzerland) · 2021
    Review
  17. Identification of RORγ as a favorable biomarker for colon cancer.The Journal of international medical research · 2021
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ri-Xiong WangDepartment of Chemotherapy, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China.
Hui LiuDepartment of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Neurobiology Research Center, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China.
Li XuDepartment of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Neurobiology Research Center, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China.
Hui ZhangDepartment of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Neurobiology Research Center, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China.
Rui-Xiang ZhouDepartment of Human Anatomy, Histology and Embryology, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; Neurobiology Research Center, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China; School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350108, P.R. China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An adequate supply of oxygen and nutrients, derived from the formation of novel blood vessels, is critical for the growth and expansion of tumor cells. It has been demonstrated that melatonin (MLT) exhibits marked

Indexed as

gastric cancerhypoxia-inducible factor-1αmelatoninnuclear receptor RZR/RORγSUMO-specific protease 1vascular endothelial growth factor

Identifiers

PMID27446366
PMCPMC4950661
OpenAlexW2425920216

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.